$61.35▲ 1.80 (3.02%)
Real-time prices · US MarketsConsensus analyst target of $83.92 is 37% above current price.
Quality
8.5
Health
9.1
Growth
8.9
Valuation
9.2
Sentiment
8.4
Analyst Target
$83.92
▲ +36.8% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
26.3×
price-to-earnings
Forward P/E
20.1×
next 12 months est.
Market Cap
$23.7B
market capitalization
Div Yield
—
dividend yield
Profit Margin
19.3%
net profit margin
Gross Margin
61.5%
revenue minus COGS
ROE
35.6%
return on equity
Beta
—
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$54 — $90
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is DXCM a good stock to buy right now?
DexCom, Inc.'s Q·Score is 8.8/10 (Very Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. Consensus analyst target of $83.92 is 37% above current price. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for DXCM?
The consensus price target for DXCM is $83.92, based on ratings from 24 Wall Street analysts. This is 36.8% above the current price of $61.35. Price targets are forward-looking estimates and not guarantees of future performance.
Is DXCM overvalued or undervalued?
DexCom, Inc. (DXCM) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 20.1×. The consensus analyst price target of $83.92 is 37% above the current price.
When does DexCom, Inc. report its next earnings?
DexCom, Inc.'s next earnings report is expected on approximately July 29, 2026.
What is DexCom, Inc.'s profit margin?
DexCom, Inc. has a net profit margin of 19.3%, which is solid for most industries. Its gross margin stands at 61.5%, indicating a high-margin business model.
Is DexCom, Inc.'s revenue growing?
DexCom, Inc. is reporting solid revenue growth of 15.0% year-over-year. Earnings are also growing at 91.9%, indicating improving profitability.
How much debt does DexCom, Inc. have?
DexCom, Inc. has a debt-to-equity ratio of 0.45×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.95×, indicating comfortable short-term liquidity.